Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial
Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe government funding status notice about operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNo substantive content changes detected; the page's core details (study design, eligibility criteria, and locations) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange Detected- Added a funding/status notice and operating details for NIH Clinical Center, plus a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check51 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' option was removed.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.